Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia.
about
Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsInflammation, mitochondria, and the inhibition of adult neurogenesisThe cytokine model of schizophrenia: emerging therapeutic strategiesThe role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophreniaIL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidaseSepsis-induced selective parvalbumin interneuron phenotype loss and cognitive impairments may be mediated by NADPH oxidase 2 activation in mice.Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophreniaDysregulation of the axonal trafficking of nuclear-encoded mitochondrial mRNA alters neuronal mitochondrial activity and mouse behaviorSocial isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneuronsHow Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.Inhibitory interneurons, oxidative stress, and schizophrenia.Deletion of selenoprotein P results in impaired function of parvalbumin interneurons and alterations in fear learning and sensorimotor gatingMouse pharmacological models of cognitive disruption relevant to schizophrenia.Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia.Adolescent onset of cortical disinhibition in schizophrenia: insights from animal models.Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia.Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats.Relationship between Interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-naïve schizophrenia: evidence for differential susceptibility?Neuroimmunological aberrations and cerebral asymmetry abnormalities in schizophrenia: select perspectives on pathogenesisNew insights on NOX enzymes in the central nervous system.Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia.Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia.Ribonucleic acid interference knockdown of interleukin 6 attenuates cold-induced hypertensionInterleukin 18 in the CNS.Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates.Gene expression analysis implicates a death receptor pathway in schizophrenia pathologyMitochondrial protection attenuates inflammation-induced impairment of neurogenesis in vitro and in vivo.Targeting NOX enzymes in the central nervous system: therapeutic opportunities.Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner.Initial evidence linking synaptic superoxide production with poor short-term memory in aged mice.Oxidative stress in schizophrenia: an integrated approach.A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial.Survival response of hippocampal neurons under low oxygen conditions induced by Hippophae rhamnoides is associated with JAK/STAT signaling.Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.Neurobiology of schizophrenia onset.Prenatal maternal immune disruption and sex-dependent risk for psychoses.The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress.
P2860
Q26741541-9776E071-F277-42B6-B22F-6C4D44B2608FQ26860239-692B1429-39BD-4476-A861-98E19115635BQ26865996-9931745C-6225-426C-9B36-A1A528038D6CQ27023087-0EDE98E5-A8A3-4C5F-8021-B345024615FBQ27349298-2F12DDFB-A5D0-42EC-8F8C-F6B6F9257912Q30278606-291F29F4-51DC-4334-A951-1A1BF5D9DA7CQ30403518-F8BEF642-5A7B-486C-8F75-1ABD723C5D2CQ30417619-4CC8AB56-40E4-456D-8EA8-03BECAE3EBD5Q30438450-D1D49090-A82A-407D-98C6-1B6349857472Q30439924-359C22FC-DB4B-4A91-833B-47422E0B1A44Q30455112-E42117B8-6BA1-4FF1-85F1-DF3C86D1A20DQ30455381-BADEF571-2894-425E-A66F-6A7FAE1A0E7EQ30457807-F150AC58-A073-4A2C-98CF-AFCABAADE9D5Q30457809-F0422DA2-B492-4A54-8358-9EAE27F28E19Q30468184-3BF1EDD1-7F43-4902-B120-E361E4C44564Q30473410-87F7D349-D184-40D9-A12D-B719C9192DBEQ30477203-1F9B5204-6BD0-431B-8815-0EE957BF133FQ33560201-3E2F58C2-A942-4FD3-BA13-CA1707B736C8Q33618965-D693792C-AE28-45DA-849F-09307FE4845FQ33632673-5DE0D4D0-C2ED-4375-B203-03B91202F74BQ33775129-6E890E3D-DBA3-4F6C-95CF-1A649A77CF21Q33789078-CA42AC13-F403-493C-8645-24374188EE21Q33854995-4EE82C20-8EB7-47D1-9587-35EF224623B0Q33950754-3B1BBCB1-FE32-423D-8552-C2FB7BD40DFDQ34095673-2FDAA4ED-646E-4FDC-B727-DE086A5F8FB5Q34195302-D20ED197-8D90-4CBF-B456-EB20374BF4C6Q34251137-31FD7EF6-DBBC-432E-8285-A3B1699BC887Q34273860-39B11555-E987-4052-B687-6A79555F7D2BQ34285497-97BAB2B5-7C1E-4FE2-8D97-5C179E35A95BQ34428194-1B3EB4EF-577E-4F59-B4A3-05CAA2B4E537Q34477409-CD121E7D-5575-4915-96A8-21A74DFACBBCQ34479837-B0970EA0-7327-4E54-8E0C-ACE25C188467Q34494844-70D7C044-AD70-472F-86B5-5188BD6062CEQ35079183-D3A85B33-BB94-4F3D-A737-57453D61506AQ35091463-BF3B29C0-BA24-41AF-8D10-C037990EE1D6Q35141115-14953AD5-2FE2-4B4E-8AEC-EF981A631E87Q35599843-243A7C0D-30EC-4E6B-8B2C-5C6941DDD20DQ35660832-F4190FD5-2FD1-47ED-BB76-1F405043D27DQ35770280-0F5E83F0-E35D-4875-9010-FC29076BD76BQ35853134-6D17C8BE-1A6D-40C0-9CE0-4FE4E14B5DA2
P2860
Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin-6 mediates the inc ...... tamine model of schizophrenia.
@en
Interleukin-6 mediates the inc ...... tamine model of schizophrenia.
@nl
type
label
Interleukin-6 mediates the inc ...... tamine model of schizophrenia.
@en
Interleukin-6 mediates the inc ...... tamine model of schizophrenia.
@nl
prefLabel
Interleukin-6 mediates the inc ...... tamine model of schizophrenia.
@en
Interleukin-6 mediates the inc ...... tamine model of schizophrenia.
@nl
P2860
P1476
Interleukin-6 mediates the inc ...... tamine model of schizophrenia.
@en
P2093
Laura L Dugan
M Margarita Behrens
P2860
P304
13957-13966
P356
10.1523/JNEUROSCI.4457-08.2008
P407
P50
P577
2008-12-01T00:00:00Z